OK. I will try again.
No-one has responded with anything reasonable so I am the sole raving lunatic.
AGS have 340M shares on issue. If they prove up 27 million pounds for themselves (eventually) and Healthgate buy the project for $10 lb, that is $270m or 80 cents a share.
If Healthgate buy the project for $15 lb, that is $405m or $1.20 a share.
At a takeover at $15 lb, add $39 opex and Heathgate's costs will be $54 per pound. The add another $3 lb for CAPEX and other costs. Total costs are $59 per lb.
At US$65 revenue, earnings before tax is $17 lb. Less tax it falls to $12 per pound.
Return for Heathgate for their trouble is $12 lb or 20% on their outlay.
Increase revenue to US$70 lb and the return becomes 30%.
OK. Maybe I was wrong before or maybe I am wrong now.
I am merely saying with only 15 million lbs proved up and spot price at US$50, the share price will struggle at the moment.
Even if AGS had 27 million pounds, the upside is limited and definitely not Gandel's $2 to $3.
- Forums
- ASX - By Stock
- AGS
- too late to keep the change, too late to pay
too late to keep the change, too late to pay, page-13
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online